[
    [
        {
            "time": "2018-10-03",
            "original_text": "['Merck', 'CEO', 'sees', 'a', 'disintermediation', 'in', 'pharma', 'like', 'the', 'cable', 'industry']",
            "features": {
                "keywords": [
                    "Merck",
                    "CEO",
                    "disintermediation",
                    "pharma",
                    "cable industry"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Merck', 'CEO', 'sees', 'a', 'disintermediation', 'in', 'pharma', 'like', 'the', 'cable', 'industry']",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Platinum', 'Equity', 'completes', '$2B', 'purchase', 'of', 'J&J’s', 'LifeScan']",
            "features": {
                "keywords": [
                    "Platinum Equity",
                    "purchase",
                    "J&J",
                    "LifeScan"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Platinum', 'Equity', 'completes', '$2B', 'purchase', 'of', 'J&J’s', 'LifeScan']",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Mergers', 'and', 'Acquisitions', 'in', 'the', 'Pharmaceuticals', 'Sector', 'in', 'Q3', '2018']",
            "features": {
                "keywords": [
                    "Mergers",
                    "Acquisitions",
                    "Pharmaceuticals",
                    "Q3 2018"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Mergers', 'and', 'Acquisitions', 'in', 'the', 'Pharmaceuticals', 'Sector', 'in', 'Q3', '2018']",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Here's', 'Why', 'J&J', '(JNJ)', 'is', 'a', 'Good', 'Bet', 'in', 'a', 'Troubled', 'Market']",
            "features": {
                "keywords": [
                    "J&J",
                    "Good Bet",
                    "Troubled Market"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "['Here's', 'Why', 'J&J', '(JNJ)', 'is', 'a', 'Good', 'Bet', 'in', 'a', 'Troubled', 'Market']",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Novartis,', 'Boston', 'Pharma', 'Ink', 'Deal', 'for', '3', 'Anti-Infective', 'Drugs']",
            "features": {
                "keywords": [
                    "Novartis",
                    "Boston Pharma",
                    "Deal",
                    "Anti-Infective Drugs"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Novartis,', 'Boston', 'Pharma', 'Ink', 'Deal', 'for', '3', 'Anti-Infective', 'Drugs']",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Merck', '&', 'Other', 'Pharma', 'Players', 'Await', 'FDA', 'Decisions', 'in', 'October']",
            "features": {
                "keywords": [
                    "Merck",
                    "Pharma Players",
                    "FDA Decisions"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Merck', '&', 'Other', 'Pharma', 'Players', 'Await', 'FDA', 'Decisions', 'in', 'October']",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['MARKETS:', 'Dow', 'hits', 'another', 'record', 'with', 'Intel,', 'Apple,', 'Caterpillar', 'leading—even', 'small', 'caps', 'are', 'on', 'board']",
            "features": {
                "keywords": [
                    "Dow",
                    "record",
                    "Intel",
                    "Apple",
                    "Caterpillar",
                    "small caps"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "market"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['MARKETS:', 'Dow', 'hits', 'another', 'record', 'with', 'Intel,', 'Apple,', 'Caterpillar', 'leading—even', 'small', 'caps', 'are', 'on', 'board']",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['A', 'Look', 'at', 'Elanco,', 'Eli', 'Lilly’s', 'Animal', 'Health', 'Business']",
            "features": {
                "keywords": [
                    "Elanco",
                    "Eli Lilly",
                    "Animal Health Business"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "['A', 'Look', 'at', 'Elanco,', 'Eli', 'Lilly’s', 'Animal', 'Health', 'Business']",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Health', 'Care', 'Sector', 'Update', 'for', '10/03/2018:', 'JNJ,', 'PFE,', 'AMGN,', 'MRK,', 'ABT,', 'ELGX,', 'NVCN,', 'KALA']",
            "features": {
                "keywords": [
                    "Health Care Sector",
                    "JNJ",
                    "PFE",
                    "AMGN",
                    "MRK",
                    "ABT",
                    "ELGX",
                    "NVCN",
                    "KALA"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "['Health', 'Care', 'Sector', 'Update', 'for', '10/03/2018:', 'JNJ,', 'PFE,', 'AMGN,', 'MRK,', 'ABT,', 'ELGX,', 'NVCN,', 'KALA']",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Bristol-Myers', 'Squibb', 'Company', '(BMY)', 'Ex-Dividend', 'Date', 'Scheduled', 'for', 'October', '04,', '2018']",
            "features": {
                "keywords": [
                    "Bristol-Myers Squibb",
                    "Ex-Dividend Date",
                    "Scheduled"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Bristol-Myers', 'Squibb', 'Company', '(BMY)', 'Ex-Dividend', 'Date', 'Scheduled', 'for', 'October', '04,', '2018']",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Dow', 'Jones', 'Futures', 'Rise', 'On', 'Italy:', 'Upwork', 'IPO', 'Set', 'To', 'Debut;', 'News', 'On', 'Nike,', 'Microsoft,', 'J&J']",
            "features": {
                "keywords": [
                    "Dow Jones Futures",
                    "Rise",
                    "Italy",
                    "Upwork IPO",
                    "Nike",
                    "Microsoft",
                    "J&J"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "market"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Dow', 'Jones', 'Futures', 'Rise', 'On', 'Italy:', 'Upwork', 'IPO', 'Set', 'To', 'Debut;', 'News', 'On', 'Nike,', 'Microsoft,', 'J&J']",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-03",
            "original_text": "['Will', 'This', 'IRS', 'Spinoff', 'Rule', 'Help', 'Pharma', 'and', 'Big', 'Tech?']",
            "features": {
                "keywords": [
                    "IRS Spinoff Rule",
                    "Pharma",
                    "Big Tech"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "['Will', 'This', 'IRS', 'Spinoff', 'Rule', 'Help', 'Pharma', 'and', 'Big', 'Tech?']",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]